Gene: R3HCC1
Official Full Name: R3H domain and coiled-coil containing 1provided by HGNC
Gene Summary: Predicted to enable nucleic acid binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36208 | R3HCC1 Knockout cell line (HeLa) | Human | R3HCC1 | 1:3~1:6 | Negative | Online Inquiry |
KO36209 | R3HCC1 Knockout cell line (HCT 116) | Human | R3HCC1 | 1:2~1:4 | Negative | Online Inquiry |
KO36210 | R3HCC1 Knockout cell line (HEK293) | Human | R3HCC1 | 1:3~1:6 | Negative | Online Inquiry |
KO36211 | R3HCC1 Knockout cell line (A549) | Human | R3HCC1 | 1:3~1:4 | Negative | Online Inquiry |
R3HCC1 Gene Knockout Cell Lines are specialized cellular models that have undergone targeted genetic modification to disable the R3HCC1 gene, which plays a critical role in various cellular processes, including transcription regulation and response to DNA damage. By creating knockout lines, researchers can study the specific biological functions of the R3HCC1 gene, elucidating its role in cellular signaling pathways and gene expression.
These cell lines operate through a mechanism of gene disruption achieved via CRISPR-Cas9 or similar genome-editing technologies. This precise gene-editing approach allows for the creation of stable cell lines that do not express R3HCC1, providing researchers with a powerful tool to analyze phenotypic changes, assess gene function, and explore downstream effects on cellular behavior, including cell proliferation, apoptosis, and response to various stimuli.
The scientific significance of R3HCC1 Gene Knockout Cell Lines extends into multiple domains, including cancer research, regenerative medicine, and the study of genetic disorders. These cell lines are invaluable in elucidating the roles of R3HCC1 in tumorigenesis and may also serve as models for understanding resistance mechanisms to therapies, thereby offering insights that can lead to the development of more effective treatment strategies.
Compared to alternative methods such as RNA interference or transient transfection, our R3HCC1 Gene Knockout Cell Lines provide stable, long-term expression profiles that allow for extensive longitudinal studies. This stability enhances data reliability, making experimental results easier to reproduce and validate. Additionally, the specificity of gene knockout ensures that observed effects are directly attributable to the absence of R3HCC1, minimizing off-target effects that can confound results.
For researchers and clinicians, the value of R3HCC1 Gene Knockout Cell Lines cannot be overstated. They facilitate cutting-edge research into gene function and disease mechanisms, providing essential insights that could lead to breakthrough discoveries. Our company's expertise in cell line development guarantees that these products are of the highest quality and rigorously validated, ensuring that your research is built on a foundation of reliability and scientific excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.